Water is the giver of life, but could it be a giver of untold medicines too?

Though key hurdles remain, there is huge potential for mRNA-based therapeutics to tackle areas of unmet need.

Walking through the mRNA manufacturing process – and its many challenges.

BASF has put substantial effort into reducing carbon emissions. A key aspect of their strategy lies in extracting and acting upon the right data.

Get a sharp perspective on the cell and gene status quo in The Medicine Maker 2022 supplement on advanced medicine

After years of progress in the courts, could one verdict in California give unproven stem cell clinics an unwelcome boost?

Can AI realistically transform data management in pharma? Yes. And it’s already begun.

Widely-used antimalarial drugs are losing efficacy. What are researchers doing to prevent that?

A growing number of deaths linked to pediatric medicines prompts the WHO to investigate “unacceptable” levels of APIs.

Why conversations on gender in drug development must go further.